Randomised, controlled study of intratumoral recombinant gamma-interferon treatment in newly diagnosed glioblastoma - Wikidata - wikimedia - TriplyDB

Randomised, controlled study of intratumoral recombinant gamma-interferon treatment in newly diagnosed glioblastoma

Randomised, controlled study of intratumoral recombinant gamma-interferon treatment in newly diagnosed glioblastoma

http://www.wikidata.org/entity/Q36079507

about

Engineered drug resistant γδ T cells kill glioblastoma cell lines during a chemotherapy challenge: a strategy for combining chemo- and immunotherapy Maintenance treatment with interferon-gamma and low-dose cyclophosphamide for pediatric high-grade glioma.Progress in active-specific immunotherapy of brain malignancies.Protooncogene bcl-2 gene transfer abrogates Fas/APO-1 antibody-mediated apoptosis of human malignant glioma cells and confers resistance to chemotherapeutic drugs and therapeutic irradiation Pharmacotherapy of malignant astrocytomas of children and adults: current strategies and future trends.Therapeutic activity of NK cells against tumors.An Eighteen Serum Cytokine Signature for Discriminating Glioma from Normal Healthy Individuals.Systemic interleukin 12 displays anti-tumour activity in the mouse central nervous system.Immunotherapeutic treatment strategies for primary brain tumors.Characterization and immunotherapeutic potential of gammadelta T-cells in patients with glioblastoma.Gammadelta T cells as immune effectors against high-grade gliomas.Dendritic cell therapy of high-grade gliomas.No role of IFITM3 in brain tumor formation in vivo.Cytokine networks in glioma.Challenges in immunotherapy presented by the glioblastoma multiforme microenvironment.Cytokines: shifting the balance between glioma cells and tumor microenvironment after irradiation.Immunological Aspects of Malignant Gliomas.Zoledronic acid enhances Vδ2 T-lymphocyte antitumor response to human glioma cell lines.IFN-γ and tumor gangliosides: Implications for the tumor microenvironment.

P2860

Q28485036-34067888-0373-4551-B1E9-DB881D809C28 Q33371019-4581524A-A016-4F9F-8601-3E3256FB9277 Q34075068-F81EE353-ACB5-4086-ADAB-47EF820D2902 Q34223630-929DB51B-F363-4FC5-A4C5-88B9E0012548 Q34387557-2D8728B0-A70B-49BF-9326-8FAD1570193A Q34552162-A31AF1DA-AF75-43BA-9441-2DB0D0F85CB7 Q35781959-92D36076-FF19-4CD8-B046-5B114B18C174 Q36115400-4DE3B9F9-7FE3-4434-82BC-CFEDAF385770 Q37117689-5DE33692-FB18-4F4A-9C02-0242E7EE4B6B Q37344951-2D5468D0-DA9B-43A9-B0C8-6EBD70262FD7 Q37587832-DEAC034B-9EE0-4BD2-B794-E55340BEFCA3 Q37594834-36E7347C-944E-44F0-99FD-3A264C635FF1 Q37699245-D736B096-47DA-4FD1-B0C9-4DFCD9C407C8 Q37886819-32F2BAA7-CD26-443F-AB35-93514FC176F2 Q37970682-49BBD058-8864-4DBB-9A68-8B33E952862E Q38227496-FD16D729-138B-457F-B3FA-AC3E249E7F87 Q38870994-28BFD4DA-3CE5-4582-A37C-8BEA4C27B5F8 Q39558094-BF111043-D7A9-4F40-BDBF-227A9EA5F652 Q50867715-923F8800-7241-4593-B9FC-CE44FCE0AF7A

P2860

Randomised, controlled study of intratumoral recombinant gamma-interferon treatment in newly diagnosed glioblastoma

http://www.wikidata.org/entity/Q36079507

description

1994 nî lūn-bûn

@nan

1994年の論文

@ja

1994年論文

@yue

1994年論文

@zh-hant

1994年論文

@zh-hk

1994年論文

@zh-mo

1994年論文

@zh-tw

1994年论文

@wuu

1994年论文

@zh

1994年论文

@zh-cn

name

Randomised, controlled study o ...... n newly diagnosed glioblastoma

@ast

Randomised, controlled study o ...... n newly diagnosed glioblastoma

@en

type

label

Randomised, controlled study o ...... n newly diagnosed glioblastoma

@ast

Randomised, controlled study o ...... n newly diagnosed glioblastoma

@en

prefLabel

Randomised, controlled study o ...... n newly diagnosed glioblastoma

@ast

Randomised, controlled study o ...... n newly diagnosed glioblastoma

@en

P1433

Q36079507-1EAA4A99-C53E-4FBE-AC14-073B02F190AA

P1476

Q36079507-5FDD8F96-A157-4FA3-9898-3D166A54354C

P2093

Q36079507-08EC5670-7A1A-4A09-ACBF-4B7554DFC907

Q36079507-10828648-FBA4-4276-9A36-69A8DBB3D2B0

Q36079507-26CE699D-C017-4AFF-9C74-63E3622A9F3F

Q36079507-2D84AD06-09E4-45BA-9119-A8B080069001

Q36079507-435DC687-AC50-4033-BECD-DBBB039A0759

Q36079507-51330581-12FE-44C3-AF06-38762D3E932A

Q36079507-C07E50C6-2D17-4DA2-8EC4-19225D878238

Q36079507-DC2DCB92-CC1C-4103-9F95-CB14A2E7F78F

Q36079507-FC814B48-4809-4435-9B4A-C677E5A46028

P2860

Q36079507-1686BB26-4858-43D0-A06C-A65BB3747C7D

Q36079507-24AF1E2E-1302-4404-A978-AF8BC036F439

Q36079507-2618116E-6951-4487-9B17-2A1CB1725CF8

Q36079507-4EC92ACF-2C5D-4E55-B399-6B29D94B5627

Q36079507-5CC155F2-56D1-43D9-A18E-C79D0DB4BA45

Q36079507-6C04A947-F6D2-4AA6-B0F3-0382F73703DC

Q36079507-7FDF5379-3CB3-40A7-B314-E1A2A5FB7F02

Q36079507-AC20FEC0-BD4B-4082-83A2-841077555EB4

Q36079507-DA276E21-8071-4BE3-8CB2-8E9ECB69C08C

Q36079507-ED71DA48-278B-4BE6-82C7-C8ECD8F0E23A

P2888

Q36079507-67D35645-BEBF-4A8D-9FFA-FDE114D9A6F4

P304

Q36079507-29254308-58F3-4AD7-B248-CE6508B94D40

P31

Q36079507-747956B6-7091-4B94-95F8-C19379198979

P356

Q36079507-0BEBAB3A-E625-4E8D-AA15-32E947D796B6

P407

Q36079507-7E8B47CE-245A-4908-8553-3ABA6D39384E

P433

Q36079507-C5AD6233-E988-4D3C-B58F-88C727913605

P478

Q36079507-AB5E649E-67D8-4B81-92F6-429E8E9117D9

P577

Q36079507-7F89A168-C312-412A-9AA9-DE0215388A54

P5875

Q36079507-8F979AD2-DE80-4A87-A8D1-C6680CBC9ADF

P698

Q36079507-47336261-5955-49B6-9A31-43C8B219FF8D

P932

Q36079507-81583C55-D98A-414A-AEFC-CA6BED94ACEF

P356

P1433

British Journal of Cancer

P1476

Randomised, controlled study o ...... n newly diagnosed glioblastoma

@en

P2093

Blomstedt G

http://www.w3.org/2001/XMLSchema#string

Färkkilä M

http://www.w3.org/2001/XMLSchema#string

Jääskeläinen J

http://www.w3.org/2001/XMLSchema#string

Kallio M

http://www.w3.org/2001/XMLSchema#string

Mäntylä M

http://www.w3.org/2001/XMLSchema#string

Paetau A

http://www.w3.org/2001/XMLSchema#string

Raininko R

http://www.w3.org/2001/XMLSchema#string

Sarelin H

http://www.w3.org/2001/XMLSchema#string

Virkkunen P

http://www.w3.org/2001/XMLSchema#string

P2860

Modulation of T-cell function by gliomas.

The role of surgery in the management of supratentorial intermediate and high-grade astrocytomas in adults.

Aspects of immunobiology and immunotherapy and uses of monoclonal antibodies and biologic immune modifiers in human gliomas.

Recombinant interferon beta: a phase I-II trial in children with recurrent brain tumors.

Intravenous recombinant interferon beta in patients with recurrent malignant gliomas: a phase I/II study.

New therapeutic approaches to treatment of malignant gliomas: chemotherapy and immunotherapy.

A randomized comparison of intra-arterial versus intravenous BCNU, with or without intravenous 5-fluorouracil, for newly diagnosed patients with malignant glioma.

Selection bias in clinical trials of anaplastic glioma.

The incidence of intracranial gliomas in southern Finland.

Clinical effect of interferon in malignant brain tumours.

P2888

P304

138-141

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BJC.1994.263

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

70

http://www.w3.org/2001/XMLSchema#string

P577

1994-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

15179770

http://www.w3.org/2001/XMLSchema#string

P698

8018525

http://www.w3.org/2001/XMLSchema#string

P932

2033327

http://www.w3.org/2001/XMLSchema#string